Respiratory Activities
Idiopathic Pulmonary Fibrosis: The Specialty Pharmacist's Role in Patient Care and Population Management
0290-0000-20-189-H01-P
Through this activity, specialty pharmacists will become familiar with the current IPF treatment paradigm and receive practice pearls for improving patient care and outcomes.
1.50
Opportunities for Delivering Optimal Care in Spinal Muscular Atrophy
0290-0000-20-185-H01-P
This activity will examine the epidemiology, pathophysiology, clinical presentation, and diagnosis of spinal muscular atrophy (SMA).
1.00
Update on COVID-19 Clinical Data and Impact on Reimbursement or Patient Access
0290-0000-20-176-H01-P
The final webinar in this 5-part series will continue the discussion about the pharmacist’s important role in optimizing the care of patients with confirmed COVID-19 diagnosis.
0.75
Psychosocial Effects and Quality of Life Impact of COVID-19
0290-0000-20-169-H01-P
This activity will define anxiety in self, patients, and staff, as well as ways to redirect to useful and healthy behaviors.
0.75